Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Melanoma 15Head and Neck Neoplasms 15Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 8Uterine Cervical Neoplasms 7Neoplasms 7Colorectal Neoplasms 7Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Carcinoma, Merkel Cell 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Kidney Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Esophageal Neoplasms 3Urogenital Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Gastrointestinal Neoplasms 2

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Diseases × atezolizumab × Head & Neck × Clear all
NCT02543645 2018-04-30

A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

Celldex Therapeutics

Phase 1 Terminated
18 enrolled
BreastDermatologicGenitourinaryHead & NeckThoracic

Clear-cell metastatic renal cell carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡